Lions Prop Asenathi Ntlabakanye Sidelined for Dragons Encounter Amid Critical Anti-Doping Disciplinary Hearing

Asenathi Ntlabakanye is ruled out of the Lions' clash with the Dragons as an independent panel reviews two anti-doping rule violations this week.

By: AXL Media

Published: Mar 24, 2026, 5:47 AM EDT

Source: Information for this report was sourced from Rugby365

Legal Proceedings Force Roster Adjustment for Ellis Park Clash

The Lions’ preparations for their Round 14 fixture against the Dragons have been significantly disrupted by the mandatory absence of Asenathi Ntlabakanye. The 26 year old front rower is currently attending a three day hearing before an independent panel to address allegations of anti-doping violations first identified in August of last year. Consequently, Ntlabakanye has been removed from team training and will not be considered for selection this Saturday, leaving the Johannesburg-based side without one of their most physically imposing scrummagers.

A Detailed Breakdown of the Chemical Allegations

The South African Institute for Drug Free Sport has issued two distinct charges against the athlete following random testing procedures. The first involves anastrozole, which is classified as a specified substance and is generally regarded as non-performance enhancing in a direct athletic context. However, the second charge involves DHEA, an unspecified substance that falls into the category of performance-enhancing agents due to its potential to increase androgen levels such as testosterone. The complexity of these dual findings has led to a wide range of speculation regarding the potential severity of the final verdict.

Transparency and Medical Supervision Cited in Defense

The South African Rugby Union has maintained a public stance that emphasizes Ntlabakanye’s transparency and adherence to medical protocols throughout the period in question. Documentation suggests that the substances were part of a treatment plan prescribed by a specialist physician in early 2025 and were administered under the oversight of a doctor specifically appointed for professional athletes. The defense is expected to argue that the player acted in good faith, relied on expert medical advice, and never sought to obtain an unfair competitive advantage through these medications.